George Lundberg, MD Editor in Chief at Cancer Commons
-
January 31, 2022
NCCN Guidelines for Patients: Peripheral T-Cell Lymphoma Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for peripheral T-cell lymphoma (PTCL).
.
-
January 31, 2022
NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for acute myeloid leukemia.
.
-
January 31, 2022
NCCN Guidelines for Patients: Small Cell Lung Cancer Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for small cell lung cancer.
.
-
January 31, 2022
NCCN Guidelines for Patients: Cervical Cancer Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for cervical cancer.
.
-
January 31, 2022
NCCN Guidelines for Patients: Kidney Cancer Bookmark
George Lundberg, MDThe nonprofit National Comprehensive Cancer Network (NCCN) publishes guidelines for patients to learn more about their diagnosis and their treatment options. Here is their 2022 update for kidney cancer.
.
-
October 18, 2021
Novel Car-T Shows ‘Promising Early Signs of Clinical Efficacy’ for Diffuse Midline Gliomas Bookmark
George Lundberg, MDHealio outlines results from a Stanford University study suggesting that a type of treatment known as CAR T-cell therapy is promising for children with diffuse midline gliomas. The treatment is still in an early phase of testing in humans.
.
-
October 18, 2021
Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases Bookmark
George Lundberg, MDThis scientific editorial article from the Journal of Clinical Oncology discusses results from a clinical trial suggesting that addition of a treatment called transarterial radioembolization to standard treatment was not effective for people with colorectal cancer liver metastases that cannot be removed by surgery.
.
-
October 18, 2021
Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience Bookmark
George Lundberg, MDThis scientific manuscript from Cureus reports results from a Toronto cancer center suggesting that stereotactic radiotherapy offers another option for palliative treatment of inoperable pancreatic cancer.
.
-
October 18, 2021
Regularly Updated List of Recent FDA Approvals for Liver Cancer Bookmark
George Lundberg, MDThis resource from the U.S. Food and Drug Administration (FDA) lists recent drug approval announcements for liver cancer and related conditions. It also provides link to information about additional approvals that may not be announced.
.
-
October 18, 2021
Running Virtual Trials with Self-Reported Brain Cancer Patient Data Bookmark
George Lundberg, MDThis scientific report from medRxiv demonstrates how self-reported data from brain cancer patients could be used to run “virtual trials” that complement traditional clinical trials by generating knowledge that could help inform precision cancer treatment.
.